Halbert Hargrove Global Advisors, LLC Zoetis Inc. Transaction History

Halbert Hargrove Global Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$145.48 - $175.02 $14,402 - $17,326	99 Added 6.73%	1,569 $261,000
Q4 2022 Jan 25, 2023	SELL	$131.14 - $157.47 $24,392 - $29,289	-186 Reduced 11.23%	1,470 $0
Q3 2022 Oct 24, 2022	SELL	$148.29 - $182.55 $2,076 - $2,555	-14 Reduced 0.84%	1,656 $246,000
Q2 2022 Aug 05, 2022	SELL	$155.97 - $200.09 $13,569 - $17,407	-87 Reduced 4.95%	1,670 $287,000
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $51,151 - $65,996	282 Added 19.12%	1,757 $331,000
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $64,111 - $81,766	-331 Reduced 18.33%	1,475 $360,000
Q3 2021 Oct 29, 2021	BUY	$189.29 - $209.69 $4,353 - $4,822	23 Added 1.29%	1,806 $351,000
Q2 2021 Jul 29, 2021	BUY	$155.9 - $187.99 $17,616 - $21,242	113 Added 6.77%	1,783 $332,000
Q1 2021 May 06, 2021	BUY	$144.0 - $169.39 $3,168 - $3,726	22 Added 1.33%	1,670 $263,000
Q4 2020 Feb 04, 2021	BUY	$157.07 - $174.35 $258,851 - $287,328	1,648 New	1,648 $273,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.